Literature DB >> 19565209

[Steroid-refractory graft-versus-host disease: extracorporeal irradiation of leucocytes induces immunotolerance].

N Schinwald1, A Rank, J Tischer, H J Kolb.   

Abstract

A 42 year-old woman develops steroid refractory graft-versus-host disease (GVHD) after second allogeneic stem cell transplantation for acute myelogenous leukemia with severe GVHD of her skin with blisters, severe GVHD of her gut with watery and bloody diarrhea and GVHD of her liver with cholestasis. In a further attempt to control GVHD extracorporeal photochemotherapy is administered. The treatment exposures peripheral mononuclear cells to photoactivated psoralen before they subsequently are given back to the patient. This approach apparently offers selective immune tolerance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19565209     DOI: 10.1007/s00108-009-2374-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  9 in total

Review 1.  Extracorporeal photochemotherapy--present and future.

Authors:  R Knobler
Journal:  Vox Sang       Date:  2000       Impact factor: 2.144

Review 2.  Pathophysiology of graft-versus-host disease.

Authors:  James L M Ferrara; Pavan Reddy
Journal:  Semin Hematol       Date:  2006-01       Impact factor: 3.851

3.  IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade.

Authors:  P A Rowlings; D Przepiorka; J P Klein; R P Gale; J R Passweg; P J Henslee-Downey; J Y Cahn; S Calderwood; A Gratwohl; G Socié; M M Abecasis; K A Sobocinski; M J Zhang; M M Horowitz
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

Review 4.  Extracorporeal photochemotherapy: a new therapeutic approach for allograft rejection.

Authors:  Roberto Dall'Amico; Luisa Murer
Journal:  Transfus Apher Sci       Date:  2002-06       Impact factor: 1.764

5.  Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease.

Authors:  E P Smith; I Sniecinski; A C Dagis; P M Parker; D S Snyder; A S Stein; A Nademanee; M R O'Donnell; A Molina; G M Schmidt; D E Stepan; N Kapoor; J C Niland; S J Forman
Journal:  Biol Blood Marrow Transplant       Date:  1998       Impact factor: 5.742

6.  The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease.

Authors:  Hildegard T Greinix; Robert M Knobler; Nina Worel; Barbara Schneider; Achim Schneeberger; Paul Hoecker; Margit Mitterbauer; Werner Rabitsch; Axel Schulenburg; Peter Kalhs
Journal:  Haematologica       Date:  2006-03       Impact factor: 9.941

7.  Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation.

Authors:  Chiara Messina; Franco Locatelli; Edoardo Lanino; Cornelio Uderzo; Graziella Zacchello; Simone Cesaro; Marta Pillon; Cesare Perotti; Claudia Del Fante; Maura Faraci; Lucia Rivabella; Elisabetta Calore; Pietro De Stefano; Marco Zecca; Giovanna Giorgiani; Alessandra Brugiolo; Adriana Balduzzi; Giorgio Dini; Luigi Zanesco; Roberto Dall'Amico
Journal:  Br J Haematol       Date:  2003-07       Impact factor: 6.998

Review 8.  Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.

Authors:  M Fimiani; M Di Renzo; P Rubegni
Journal:  Br J Dermatol       Date:  2004-06       Impact factor: 9.302

9.  Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loading.

Authors:  Maria Salskov-Iversen; Carole L Berger; Richard L Edelson
Journal:  J Immune Based Ther Vaccines       Date:  2005-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.